In leukemia, SRPK enhances the splicing regulatory capacity of SRSF1 on cyclin A1 pre-mRNA by phosphorylating SRSF1 at S422, thereby accelerating cell cycle progression and promoting tumor cell proliferation [357]. The gene discussed is SRSF1; the disease is neoplasm.